Abstract
Prosthetic valve thrombosis is associated with high mortality. The treatment of choice remains operation. This is a case report of the successful combination therapy of tissue plasminogen activator and urokinase for an isolated thrombosed prosthetic mitral valve in a postpartum patient in whom operation was thought to carry an unacceptable risk. Combined thrombolytic therapy or therapy with a single agent with a long half-life and a prolonged infusion time is suggested as an emergent treatment option for prosthetic mitral valve thrombosis.
Original language | English (US) |
---|---|
Pages (from-to) | 159-161 |
Number of pages | 3 |
Journal | The Annals of Thoracic Surgery |
Volume | 55 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1993 |
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine